Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-04-25 00:00:00 ET · period of report 2022-04-21 · accession 0000874015-22-000101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-25 | 2022-04-21 | IONS | Swayze Eric | EVP Research | S - Sale | $44.15 | -378 | 20.4K | -2% | -$16.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-21 | S | D | 378 | $44.15 | 20,353 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. |